TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/13/2026
Back to search
Official data from USPTO
CELLECTIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLECTIS
ST13
US500000076210655Class
1, 5, 9, 42
Filing
76210655
Registration
2872075
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
08/14/2026
Trademark type
Word
Nice classes
1, 5, 9, 42
Filing date
02/13/2001
Registration date
08/10/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/13/2024
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2001-09-00
First use in commerce
2001-09-00
Drawing code
1
Owner type
16
Owner location
Paris, FR
Examiner
CHARLON, BARNEY
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cellectis S.A.
Cellectis S.A.
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemicalbiotechnological products intended for industryagriculturehorticulturenamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissors; ready to use genomic recombination systemmeganuclease recombination agents for use in genetic engineering of cells and animalsnamely rodent and fishfor scientificlaboratory or medical research; chemicalbiochemicalbiotechnological and bacteriological products intended for research laboratories and control laboratoriesnamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination agents for use in connection with cells and animals for scientificlaboratory or medical research; chemicalbiochemicalbiotechnological products and bacteriological preparations for sciencesnamely polypeptides for in vivo and in vitro genetic engineering; natural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination agents for use in connection with cells and animals for scientificlaboratory or medical research; diagnostic preparationnamely natural and engineered meganucleases and endonucleasesmolecular scissors for scientific or research use; proteins as raw materials; microorganisms used for producing therapeutical compounds or vaccines; chemical and biochemical preparations for medicalpharmaceutical and veterinary usenamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination agents for scientific or research use
Class 5
Pharmaceuticalveterinary and health-care productsnamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination systemcells engineered by meganulease recombination system for use in genetic or viral diseases; microorganism cultures and preparation for medicalpharmaceutical and veterinary usenamely microoganisms engineered by meganuclease recombination system for use in genetic or viral diseasescancers and vaccines; microorganisms producing polypeptides for in vivo and vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination system for use in genetic or viral diseases; bacteriological preparations for medicalpharmaceutical and veterinary use namely bacteriological preparations engineered by meganuclease recombination system; bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination system; drugs for veterinary usenamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic and acid vectorsmolecular scissors for use in genetic or viral diseases; biological preparation for medicalpharmaceutical and veterinary use namely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleaesnucleic and vectorsmolecular scissorsready to use genomic recombination systemcells engineered by meganuclease recombination system for use in genetic or viral diseases; chemopharmaceutical preparations; diagnostic preparations for clinical or medical laboratory use
Class 9
Scientific devices and instruments enabling implementation of biochemical analysis techniques and molecular biology techniquesnamely automated biochemical analyserautomated protein production and protein purification devicesbiochemicalbiological automated assay devicesnucleic acid break analyseranalyzer for automatically measuring and researching interactions of biomoleculesdevice for protein-nucleic acid interaction analysis; apparatus for use in analysis and array-testsqualitative and quantitative detection of analytes in samplesDNA sequencingreceptor-ligand interactionprotein analysismass-spectrometrynucleic acid hybridization and detectionthermo-cycler systemsmicroarray-printermicroarray-reader; scientific devices and instruments enabling the mapping of the biological activities of all molecules; information processing equipmentcomputer software for molecular designsequence analysissequence generationdesign and analysis for moleculesnamely polypeptides or polynucleotides used in genetic engineeringdesign and analysis of meganucleases and endonucleases and for design and analysis of genetic recombination systemshardware and component partsprocessorsmemory banksperipheral controllers; multimedia productsprerecorded magnetic tapesCD-ROMscontaining image and sound recordings in the fields of chemistrybiologybiochemistrymolecular biologybacteriology; software programs namelysoftware for providing an on-line computer database in the field of pharmaceuticals and biotechnology; software for searchingretrievingstoringmaintaining and managing data in the field of pharmaceuticals and biotechnology; software for use in the field of scientific information management; software for use in drug discovery; software for biomolecules analysisnucleic acids and proteins sequences evaluationchemicalmedical and biological data bank searches and analysisphysiological data analysisgenetic data analysischemical formulae analysisstructural prediction for biological and chemical molecules; software for writing biological molecule sequence; molecular design software for analysissimulation and design of biologicalchemicalmaterial systems; software for molecular design in the biotechnology and pharmaceutical field; software for use in biological and chemical modelinganalysis and information management; software for integrated global management
Class 42
Scientific and industrial research; research in geneticmedicalpharmaceutical and veterinary fields; research in chemistrybiologybiochemistrymolecular biologybacteriology; scientific analysis; research and development for others of techniques of biochemical analysisbiological analysismolecular biology techniques; research and development for others of new molecules intended for industry; laboratory research in the fields of biotechnologyhuman and veterinary medicinegenetic engineeringprotein designdrug designgenetic therapymolecular biologyagriculture; medical services; studies of technical projects in the field of biotechnologyhuman and veterinary medicinegenetic engineeringprotein designdrug designgenetic therapymolecular biologyagriculture; testinganalysis and evaluation of engineering works for others; licensing of patents and intellectual property; computer programming for othersdevelopment for others of multimedia software programs
Publications
History of USPTO decisions and trademark events.
52 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/13/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/13/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/13/2024
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
11/13/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/13/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/10/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/18/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/18/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/18/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/18/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/18/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/18/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/18/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/10/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/12/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/12/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/12/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
02/10/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/10/2015
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/10/2015
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/27/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/27/2010
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
08/06/2010
E815
TEAS SECTION 8 & 15 RECEIVED
08/06/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2004
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/01/2004
DOCK
ASSIGNED TO EXAMINER
05/26/2004
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/26/2004
CFIT
CASE FILE IN TICRS
05/21/2004
IUAF
USE AMENDMENT FILED
05/11/2004
FAXX
FAX RECEIVED
05/11/2004
PAPER RECEIVED
05/11/2004
EX1G
SOU EXTENSION 1 GRANTED
12/09/2003
EXT1
SOU EXTENSION 1 FILED
11/13/2003
PAPER RECEIVED
11/13/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/13/2003
PUBO
PUBLISHED FOR OPPOSITION
02/18/2003
NPUB
NOTICE OF PUBLICATION
01/29/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/16/2002
CNEA
EXAMINERS AMENDMENT MAILED
11/22/2002
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/21/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2002
PAPER RECEIVED
09/30/2002
CNFR
FINAL REFUSAL MAILED
05/20/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2001
CNRT
NON-FINAL ACTION MAILED
06/15/2001
DOCK
ASSIGNED TO EXAMINER
06/12/2001
Continuous trademark protection
Get notified about every new filing that threatens CELLECTIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.